| [1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: Cancer J Clin, 2018, 68(6): 394-424.
|
| [2] |
Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| [3] |
Kitano S, Iso Y, Moriyama M, et al. Laparoscopy-assisted Billroth I gastrectomy[J]. Surg Laparosc Endosc, 1994, 4(2): 146-148.
|
| [4] |
Torre LA, Siegel RL, Ward EM, et al. Global Cancer Incidence and Mortality Rates and Trends--An Update[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(1): 16-27.
|
| [5] |
Zhao JK, Wu M, Kim CH, et al. Jiangsu Four Cancers Study: a large case-control study of lung, liver, stomach, and esophageal cancers in Jiangsu Province, China[J]. Eur J Cancer Prev, 2017, 26(4): 357-364.
|
| [6] |
Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial) [J]. Anna Surg, 2010, 251(3): 417-420.
|
| [7] |
Cho SY, Lee KS, Kim JH, et al. Effect of combined systematized behavioral modification education program with desmopressin in patients with nocturia: a prospective, multicenter, randomized, and parallel study[J]. Int Neurourol J, 2014, 18(4): 213-220.
|
| [8] |
Honda M, Hiki N, Kinoshita T, et al. Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study[J]. Ann Surg, 2016, 264(2): 214-222.
|
| [9] |
Kim W, Kim HH, Han SU, et al. Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01) [J]. Ann Surg, 2016, 263(1): 28-35.
|
| [10] |
Katai H, Mizusawa J, Katayama H, et al. Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912[J]. Gastric Cancer, 2017, 20(4): 699-708.
|
| [11] |
Huang CM, Zheng CH. Laparoscopic Gastrectomy for Gastric Cancer[J]. Springer, 2015.
|
| [12] |
Huang CM, Zheng CH, Li P, et al. Atlas of Laparoscopic Gastrectomy for Gastric Cancer[J]. Springer, 2019.
|
| [13] |
Chen QY, Huang CM, Lin JX, et al. Laparoscopic Infrapyloric Area Lymph Node Dissection with No. 14v Enlargement for Advanced Lower Gastric Cancer in Middle Colic Vein Approach[J]. Ann Surg Oncol, 2016, 23(3): 951.
|
| [14] |
Huang CM, Chen QY, Lin JX, et al. Laparoscopic Suprapancreatic Lymph Node Dissection for Advanced Gastric Cancer Using a Left-Sided Approach[J]. Ann Surg Oncol, 2015, 22(7): 2351.
|
| [15] |
Chen RF, Huang CM, Chen QY, et al. Why the Proximal Splenic Artery Approach is the Ideal Approach for Laparoscopic Suprapancreatic Lymph Node Dissection in Advanced Gastric Cancer? A Large-Scale Vascular-Anatomical-Based Study[J]. Medicine (Baltimore), 2015, 94(18): e832.
|
| [16] |
Liang H. Standardize the lymphadenectomy from the rules of lymph nodes metastasis for advanced gastric cancer (in Chinese) [J]. Chin J Gastrointest Surg, 2011, 14(2): 86-89.
|
| [17] |
Huang CM, Chen QY, Lin JX, et al. Laparoscopic spleen-preserving no. 10 lymph node dissection for advanced proximal gastric cancer using a left approach[J]. Ann Surg Oncol, 2014, 21(6): 2051.
|
| [18] |
Jia-Bin W, Chang-Ming H, Chao-Hui Z, et al. Laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer in left approach: a new operation procedure[J]. World J Surg Oncol, 2012, 10: 241.
|
| [19] |
Huang CM, Chen QY, Lin JX, et al. Huang's three-step maneuver for laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer[J]. Chin J Cancer Res, 2014, 26(2): 208-210.
|
| [20] |
Yu J, Hu J, Huang C, et al. The impact of age and comorbidity on postoperative complications in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: results from the Chinese laparoscropic gastrointestinal surgery study (CLASS) group[J]. Eur J Surg Oncol, 2013, 39(10): 1144-1149.
|
| [21] |
Hu YF, Huang CM, Sun YH, et al. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial[J]. J Clin, 2016, 34(12): 1350-1357.
|
| [22] |
Yu J, Huang C, Sun Y, et al. Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial[J]. JAMA, 2019, 321(20): 1983-1992.
|
| [23] |
Monig SP, Collet PH, Baldus SE, et al. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus[J]. J Surg Oncol, 2001, 76(2): 89-92.
|
| [24] |
Sasada S, Ninomiya M, Nishizaki M, et al. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer[J]. Anticancer Res, 2009, 29(8): 3347-3351.
|
| [25] |
Zhu GL, Sun Z, Wang ZN, et al. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach[J]. J Surg Oncol, 2012, 105(8): 786-792.
|
| [26] |
Methasate A, Trakarnsanga A, Akaraviputh T, et al. Lymph node metastasis in gastric cancer: result of D2 dissection[J]. J Med Assoc Thai, 2010, 93(3): 310-317.
|
| [27] |
Huang CM, Zhang JR, Zheng CH, et al. A 346 case analysis for laparoscopic spleen-preserving no.10 lymph node dissection for proximal gastric cancer: a single center study[J]. PLoS One, 2014, 9(9): e108480.
|
| [28] |
Zhang CH, Wu AW, Li ZY, et al. [Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques] [J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2011, 14(8): 589-592.
|
| [29] |
Shin SH, Jung H, Choi SH, et al. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer[J]. Ann Surg Oncol, 2009, 16(5): 1304-1309.
|
| [30] |
Guo X, Peng Z, Lv XH, et al. Randomized controlled trial comparing short-term outcomes of laparoscopic and open spleen-preserving splenic hilar lymphadenectomy for advanced proximal gastric cancer: An interim report[J]. J Surg Oncol, 2018, 118(8): 1264-1270.
|
| [31] |
Zhang CH, Zhan WH, He YL, et al. Spleen preservation in radical surgery for gastric cardia cancer[J]. Ann Surg Oncol, 2007, 14(4): 1312-1319.
|
| [32] |
Ma ZM, Shi G, Chen X, et al. Laparoscopic splenic hilar lymph node dissection for advanced gastric cancer: to be or not to be[J]. Ann Transl Med, 2019, 7(14): 343.
|
| [33] |
Zheng CH, Xu YC, Zhao G, et al. Safety and feasibility of laparoscopic spleen-preserving No. 10 lymph node dissection for locally advanced upper third gastric cancer: a prospective, multicenter clinical trial[J]. Surg Endosc, 2020, 34(11): 5062-5073.
|
| [34] |
Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database[J]. J Clin Oncol, 2005, 23(28): 7114-7124.
|
| [35] |
Son T, Hyung WJ, Lee JH, et al. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer[J]. Cancer, 2012, 118(19): 4687-4693.
|
| [36] |
Seevaratnam R, Bocicariu A, Cardoso R, et al. A meta-analysis of D1 versus D2 lymph node dissection[J]. Gastric Cancer, 2012, 15 Suppl 1: S60-S69.
|
| [37] |
Songun I, Putter H, Kranenbarg EMK, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial[J]. Lancet Oncol, 2010, 11(5): 439-449.
|
| [38] |
Vahrmeijer AL, Hutteman M, van der Vorst JR, et al. Image-guided cancer surgery using near-infrared fluorescence[J]. Nat Rev Clin Oncol, 2013, 10(9): 507-518.
|
| [39] |
Valente SA, Al-Hilli Z, Radford DM, et al. Near Infrared Fluorescent Lymph Node Mapping with Indocyanine Green in Breast Cancer Patients: A Prospective Trial[J]. J Am Coll Surg, 2019, 228(4): 672-678.
|
| [40] |
Yamashita S, Tokuishi K, Anami K, et al. Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer[J]. J Thorac Cardiovasc Surg, 2011, 141(1): 141-144.
|
| [41] |
Tajima Y, Murakami M, Yamazaki K, et al. Sentinel node mapping guided by indocyanine green fluorescence imaging during laparoscopic surgery in gastric cancer[J]. Ann Surg Oncol, 2010, 17(7): 1787-1793.
|
| [42] |
Yano K, Nimura H, Mitsumori N, et al. The efficiency of micrometastasis by sentinel node navigation surgery using indocyanine green and infrared ray laparoscopy system for gastric cancer[J]. Gastric Cancer, 2012, 15(3): 287-291.
|
| [43] |
Huh YJ, Lee HJ, Kim TH, et al. Efficacy of Assessing Intraoperative Bowel Perfusion with Near-Infrared Camera in Laparoscopic Gastric Cancer Surgery[J]. J Laparoendosc Adv Surg Tech A, 2019, 29(4): 476-483.
|
| [44] |
Chen QY, Xie JW, Zhong Q, et al. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial[J]. JAMA Surg, 2020, 155(4): 300-311.
|